281 related articles for article (PubMed ID: 29179687)
21. Faecal microbiota transplantation is promising but not a panacea.
Sadowsky MJ; Khoruts A
Nat Microbiol; 2016 Feb; 1():16015. PubMed ID: 27572174
[No Abstract] [Full Text] [Related]
22. Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a 3-year, single-centre cohort study.
Ianiro G; Valerio L; Masucci L; Pecere S; Bibbò S; Quaranta G; Posteraro B; Currò D; Sanguinetti M; Gasbarrini A; Cammarota G
Clin Microbiol Infect; 2017 May; 23(5):337.e1-337.e3. PubMed ID: 28057560
[TBL] [Abstract][Full Text] [Related]
23. [Faecal microbiota transplantation for the treatment of bowel disease].
Rode AA; Chehri M; Petersen AM; Bytzer P
Ugeskr Laeger; 2017 Jul; 179(31):. PubMed ID: 28869008
[TBL] [Abstract][Full Text] [Related]
24. Faecal microbiota transplantation--the Austrian approach.
Kump PK; Krause R; Allerberger F; Högenauer C
Clin Microbiol Infect; 2014 Nov; 20(11):1106-11. PubMed ID: 25274251
[TBL] [Abstract][Full Text] [Related]
25. Clostridium difficile Infection and Fecal Microbiota Transplant.
Liubakka A; Vaughn BP
AACN Adv Crit Care; 2016 Jul; 27(3):324-337. PubMed ID: 27959316
[TBL] [Abstract][Full Text] [Related]
26. Establishing a Fecal Microbiota Transplant Service for the Treatment of Clostridium difficile Infection.
Costello SP; Tucker EC; La Brooy J; Schoeman MN; Andrews JM
Clin Infect Dis; 2016 Apr; 62(7):908-14. PubMed ID: 26628567
[TBL] [Abstract][Full Text] [Related]
27. Faecal microbiota transplantation: what's beyond Clostridium difficile infection?
Tamilarasan AG; Krishnananthan T
Eur J Gastroenterol Hepatol; 2021 Apr; 33(4):487-494. PubMed ID: 33177380
[TBL] [Abstract][Full Text] [Related]
28. [Fecal microbiota transplantation in recurrent Clostridium difficile infection. Report of one case].
Moscoso F; Simian D; Rivera D; Acuña G; Quera R
Rev Med Chil; 2015 Apr; 143(4):531-5. PubMed ID: 26204547
[TBL] [Abstract][Full Text] [Related]
29. Faecal microbiota transplantation-A clinical view.
Mattner J; Schmidt F; Siegmund B
Int J Med Microbiol; 2016 Aug; 306(5):310-315. PubMed ID: 26924753
[TBL] [Abstract][Full Text] [Related]
30. Faecal microbiota transplantation as salvage therapy for fulminant Clostridium difficile infections.
Million M; Hocquart M; Seghboyan JM; Griffiths K; Halfon P; Lagier JC; Brouqui P; Raoult D
Int J Antimicrob Agents; 2015 Aug; 46(2):227-8. PubMed ID: 26092095
[No Abstract] [Full Text] [Related]
31. Fecal microbiota transplantation in patients with cancer undergoing treatment.
Blackburn LM; Bales A; Caldwell M; Cordell L; Hamilton S; Kreider H
Clin J Oncol Nurs; 2015 Feb; 19(1):111-4. PubMed ID: 25689657
[TBL] [Abstract][Full Text] [Related]
32. Successful therapy of Clostridium difficile infection with fecal microbiota transplantation.
Konturek PC; Koziel J; Dieterich W; Haziri D; Wirtz S; Glowczyk I; Konturek K; Neurath MF; Zopf Y
J Physiol Pharmacol; 2016 Dec; 67(6):859-866. PubMed ID: 28195066
[TBL] [Abstract][Full Text] [Related]
33. A standardised model for stool banking for faecal microbiota transplantation: a consensus report from a multidisciplinary UEG working group.
Keller JJ; Ooijevaar RE; Hvas CL; Terveer EM; Lieberknecht SC; Högenauer C; Arkkila P; Sokol H; Gridnyev O; Mégraud F; Kump PK; Nakov R; Goldenberg SD; Satokari R; Tkatch S; Sanguinetti M; Cammarota G; Dorofeev A; Gubska O; Ianiro G; Mattila E; Arasaradnam RP; Sarin SK; Sood A; Putignani L; Alric L; Baunwall SMD; Kupcinskas J; Link A; Goorhuis AG; Verspaget HW; Ponsioen C; Hold GL; Tilg H; Kassam Z; Kuijper EJ; Gasbarrini A; Mulder CJJ; Williams HRT; Vehreschild MJGT
United European Gastroenterol J; 2021 Mar; 9(2):229-247. PubMed ID: 33151137
[TBL] [Abstract][Full Text] [Related]
34. Faecal microbiota transplantation: Key points to consider.
Bourlioux P;
Ann Pharm Fr; 2015 May; 73(3):163-8. PubMed ID: 25747146
[TBL] [Abstract][Full Text] [Related]
35. Faecal microbiota transplantation in Australia: bogged down in regulatory uncertainty.
Costello SP; Bryant RV
Intern Med J; 2019 Feb; 49(2):148-151. PubMed ID: 30754077
[No Abstract] [Full Text] [Related]
36. The potential for emerging therapeutic options for Clostridium difficile infection.
Mathur H; Rea MC; Cotter PD; Ross RP; Hill C
Gut Microbes; 2014; 5(6):696-710. PubMed ID: 25564777
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic manipulation of the microbiota: past, present, and considerations for the future.
Young VB
Clin Microbiol Infect; 2016 Nov; 22(11):905-909. PubMed ID: 27619640
[TBL] [Abstract][Full Text] [Related]
38. Clostridium difficile colitis: A clinical review.
Ong GK; Reidy TJ; Huk MD; Lane FR
Am J Surg; 2017 Mar; 213(3):565-571. PubMed ID: 28131326
[TBL] [Abstract][Full Text] [Related]
39. Challenges in fecal donor selection and screening for fecal microbiota transplantation: A review.
Woodworth MH; Carpentieri C; Sitchenko KL; Kraft CS
Gut Microbes; 2017 May; 8(3):225-237. PubMed ID: 28129018
[TBL] [Abstract][Full Text] [Related]
40. Faecal microbiota transplantation for recurrent Clostridium difficile infection and beyond: risks and regulation.
Goldenberg SD
J Hosp Infect; 2016 Feb; 92(2):115-6. PubMed ID: 26792682
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
